Similar studies have also found that mutant p53 reduces the activation of T cells via the transcriptional inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2) and the activation of protein kinase B (AKT), thereby promoting the immune escape and growth of tumor cells [87]. Here, TP53 is linked to neoplasm.